Sijin Guo

Sijin Guo, PhD is currently serving as the Associate Director of Oligonucleotide Chemistry at Synoligo Biotechnologies Inc. Prior to this role, Sijin held positions at The Janssen Pharmaceutical Companies of Johnson & Johnson and LGC, Biosearch Technologies. With a background in RNA Nanotechnology and Nanobiotechnology, Sijin has extensive experience in developing therapeutic RNA nanoparticles and oligonucleotide therapeutics for targeted drug delivery. Sijin's research and leadership roles have significantly contributed to the advancement of oligo synthesis platforms and process development for pre-clinical and clinical oligo programs.